Krystal Biotech buy Chardan Capital
Start price
20.02.25
/
50%
€172.25
Target price
20.02.26
€208.60
Performance (%)
25.40%
Price
15:46
€216.00
Summary
This prediction is currently active. The prediction currently has a performance of 25.40%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -3.108% | -3.108% |
| iShares Core DAX® | 2.032% | 3.499% |
| iShares Nasdaq 100 | -0.145% | -1.849% |
| iShares Nikkei 225® | 4.507% | 1.976% |
| iShares S&P 500 | 0.331% | -0.103% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Chardan Capital from $212.00 to $218.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25